Validation of assessment methods for the apparent diffusion coefficient in a clinical trial of axial spondyloarthritis patients treated with golimumab

Ähnliche Einträge

• Test–retest repeatability of the apparent diffusion coefficient in sacroiliac joint MRI in patients with axial spondyloarthritis and healthy individuals
  von: Møller, Jakob M, et al.
  Veröffentlicht: (2020)
• Repeatability and reproducibility of MRI apparent diffusion coefficient applied on four different regions of interest for patients with axial spondyloarthritis and healthy volunteers scanned twice within a week
  von: Møller, Jakob Møllenbach, et al.
  Veröffentlicht: (2020)
• Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial
  von: Krabbe, Simon, et al.
  Veröffentlicht: (2018)
• Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers
  von: Anne Gitte Loft, et al.
  Veröffentlicht: (2024-02-01)
• Peripheral Enthesitis Detected by Ultrasonography in Patients With Axial Spondyloarthritis—Anatomical Distribution, Morphology, and Response to Tumor Necrosis Factor-Inhibitor Therapy
  von: Seven, Sengul, et al.
  Veröffentlicht: (2020)